Figure 4.
(A) Confirmation of prognostic risk scores in the TCGA cohort. (B) Polygenic model risk score distribution in TCGA cohort. (C) Survival status and duration of LUAD patients in TCGA cohort. (D) Confirmation of prognostic risk scores in the GSE68571 cohort. (E) Polygenic model risk score distribution in the GSE68571 cohort. (F) Survival status and duration of LUAD patients in the GSE68571 cohort.